ArticleBritish journal of cancer2009

Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts.

P Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.